News

Nymox has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.

Researchers have discovered the structure of the molecular switch that controls communication between tumour cells.

New analysis from Frost & Sullivan, reveals that the predictive medicine, pharmacogenomic, and prenatal and newborn screening will experience significant growth over the next decades.

GE Healthcare and CTT will consider exploring a broader use of the CTT technology in medical imaging.

Use of Transgenomic's technology enabled detection of disease-associated genetic mutation at several post-therapy time points.

Cedara will introduce a clinical product line named Cedara OncologyWorks at this year's ASTRO conference.

Using the reagents from Tm Bioscience, PathGroup have developed an upgraded CF assay.

The NIH anticipates spending $150 million over five years to renew its Pharmacogenetics Research Network.

Patients with a specific combination of polymorphisms in genes responsible for the production of C-reactive protein (CRP) and interleukin-6 (IL-6) suffered stroke at three times higher rate.

The patent application is being filed in conjunction with major research institutions in the Houston area, with Power3 having an exclusive license to commercialize the technology involved.